|
LINKS
| |
Scheda a cura di Marco Chilosi (GYM)
LINFOMI
T CD16+
L'analisi
dell'espressione di CD16 nei processi linfoproliferativi è di solito effettuata
mediante analisi immunofenotipica in citometria a flusso. La disponibilità di
un anticorpo utilizzabile su materiale istopatologico (incluso in
paraffina) rende possibile la ricerca
di CD16 su materiale di routine per caratterizzare le neoplasie T/NK (linfonodo,
biopsia osteomidollare, polmone, etc.).
| Large granular
lymphocytic leukemia, T-cell type: |
| TdT-, PanT+ (CD2,
CD3+, CD5+/-, CD7-), TCR+, CD4-, CD8+, CD16+,
CD56-,
CD57+, CD25-; most
cases show clonal rearrangements of TCR genes |
| Large granular
lymphocytic leukemia, NK cell type: |
| TdT-, CD2+, CD3-,
TCR-, CD4-, CD8+/-, CD16+/-, CD56+/-, CD57+/-, CD25-; TCR and Ig genes are
germline |
| Nasal/nasal type
T/NK cell (angiocentric) lymphoma: |
|
TdT-, CD2+, CD5-/+,
CD7-/+, CD3-/+, may be CD4+ or CD8+, CD56+/-;
CD16+/-
usually no rearranged TCR or
Ig genes; often EBV positive
|
figura
1. intensa espressione di CD16 nelle cellule macrofagiche presenti
nella
polpa rossa splenica

figura
2. intensa espressione di CD16 nelle cellule macrofagiche presenti in
un linfoma T (CD16-).

figura
3. linfoma T/NK cutaneo CD16+
figura 4. linfoma T/NK del polmone (nasal-type) CD16+

-
-
- Int J Cancer. 1999 Jun 11;81(6):865-70.
- Immunophenotypic and genotypic characterization of
nasal lymphoma with polymorphic reticulosis morphology.
- Ohsawa M, Nakatsuka S, Kanno H, Miwa H, Kojya S, Harabuchi Y, Yang WI,
Aozasa K. Department of Pathology, Osaka University Medical School,
Suita, Japan.
- Nasal lymphoma with polymorphic reticulosis (PR) morphology is now
categorized as T/natural killer (T/NK) cell lymphoma. In this study,
immunophenotypes and genotypes of proliferating cells in 21 cases with PR
were examined. The patients included 13 men and 8 women ranging in age
from 20 to 74 (median 37) years. All patients presented with lesions in
the upper respiratory tract, mostly in the nasal cavity. Histological
specimens obtained from the primary lesions (19 cases) and metastatic
cervical lymph nodes (2 cases) were used for analyses. Histologically,
polymorphous proliferation was found in 20 cases, and these were thus
diagnosed as PR. A monomorphous pattern was found in the remaining last
case. Immunohistochemical analysis revealed that the proliferating cells
were CD56 (123C3)+ and/or CD16 (2H7)+, TIA-1+ and frequently stained CD3
epsilon+. Tumor cells were frequently stained positively with monoclonal
antibodies (mAbs) for T lymphocytes, but were negative for T-cell receptor
(TCR) beta and delta chain expression. In situ hybridization analysis
using an Epstein-Barr virus-encoded early RNA 1 (EBER-1) probe revealed
positive signals in 13 of the 15 cases examined. Southern blotting
analysis for clonality of the Epstein-Barr virus (EBV) genome in 12
positive cases confirmed the presence of monoclonal proliferation in 7
cases. The pattern of TCR gamma chain gene rearrangement was examined by
PCR analysis of DNA from tumor tissues by the denaturing gradient gel
electrophoresis method. The results demonstrated no clonal rearrangement
in any of the 21 cases examined, including 7 cases with proven clonal
proliferation of EBV-infected cells, indicating the absence of T-cell
clones. Our findings strongly suggested that nasal T-cell lymphoma is in
fact a NK cell lymphoma. PMID: 10362131 [PubMed - indexed for MEDLINE]
-
- Pathol Res Pract. 2002;198(5):369-73.
- Primary bony peripheral T-cell lymphoma mimicking
nasal type NK/T-cell lymphoma: a case report.
Chuang SS, Lin CN, Li CY.
Department of Pathology, Chi-Mei Medical Center, Yung-kang City, Tainan,
Taiwan. ssc6061@ms16.hinet.net
Primary bony lymphomas are rare, and nearly all are high-grade B-cell
lymphomas. Natural killer (NK)/T-cell lymphomas are highly aggressive
lymphomas of NK- or T-cell lineage with predominant extranodal
presentation and are divided into nasal and nasal-type (extra-nasal). We
report a primary bony peripheral T-cell lymphoma mimicking NK/T-cell
lymphoma, nasal type. A 22-year-old Taiwanese male presented with a
frontal skull bone mass noted for 3 weeks, and received craniectomy with
tumor removal. His tumor showed extensive coagulative necrosis with
angioinvasion by large lymphoma cells expressing CD2, CD8, CD16, CD43,
CD45, CD45RO, CD56, T-cell intracellular antigen-1, and granzyme B, but
not CD3, CD4, CD20, CD57, CD68, and betaF1. In situ hybridization for
Epstein-Barr virus-encoded mRNA was negative. Polymerase chain reaction
study of formalin-fixed tissue showed clonal rearrangement of the T-cell
receptor-gamma chain gene. The diagnosis was peripheral T-cell lymphoma,
unspecified subtype. The initial stage was I(EA). His lymphoma was
refractory to chemotherapy, and bony metastases developed in the right
iliac bone 2 months later. He died of disease after 6 months without
autopsy. We emphasize the importance of detailed immunohistochemical and
gene rearrangement studies for the classification of malignant lymphomas
via a very rare primary bony lymphoma of peripheral T-cell subtype.
PMID: 12092774 [PubMed - indexed for MEDLINE]
back
to CD16
|